(0.23%) 5 143.50 points
(0.12%) 38 489 points
(0.36%) 17 911 points
(-0.61%) $83.34
(1.77%) $1.957
(-0.11%) $2 344.70
(-0.07%) $27.52
(2.89%) $948.75
(-0.03%) $0.934
(-0.07%) $11.02
(-0.25%) $0.798
(1.90%) $93.61
Live Chart Being Loaded With Signals
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. develops, manufactures, and sells pharmaceutical products in Mainland China and internationally. It operates in five segments: Pharmaceutical Manufacturing, Medical Devices and Medical Diagnosis, Healthcare Service, Pharmaceutical Distribution and Retail, Other Business segments...
Stats | |
---|---|
आज की मात्रा | 4.96M |
औसत मात्रा | 3.25M |
बाजार मूल्य | 60.48B |
EPS | HKD0.186 ( 2023-09-30 ) |
Last Dividend | HKD0.460 ( 2023-07-31 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | 12.90 |
ATR14 | HKD0.0150 (0.12%) |
मात्रा सहसंबंध
Shanghai Fosun सहसंबंध
10 सबसे अधिक सकारात्मक सहसंबंध |
---|
10 सबसे अधिक नकारात्मक सहसंबंध |
---|
क्या आप जानते हैं?
कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।
कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।
Shanghai Fosun सहसंबंध - मुद्रा/वस्त्र
Shanghai Fosun वित्तीय
Annual | 2023 |
राजस्व: | HKD41.40B |
सकल लाभ: | HKD19.80B (47.84 %) |
EPS: | HKD0.890 |
FY | 2023 |
राजस्व: | HKD41.40B |
सकल लाभ: | HKD19.80B (47.84 %) |
EPS: | HKD0.890 |
FY | 2022 |
राजस्व: | HKD43.95B |
सकल लाभ: | HKD20.78B (47.28 %) |
EPS: | HKD1.430 |
FY | 2021 |
राजस्व: | HKD39.01B |
सकल लाभ: | HKD18.78B (48.14 %) |
EPS: | HKD1.850 |
Financial Reports:
No articles found.
Shanghai Fosun Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0.460 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | HKD0.210 | 2013-07-04 |
Last Dividend | HKD0.460 | 2023-07-31 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 11 | -- |
Total Paid Out | HKD4.51 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.42 | -- |
Div. Sustainability Score | 7.35 | |
Div.Growth Potential Score | 4.70 | |
Div. Directional Score | 6.03 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
6033.HK | Ex Dividend Knight | 2023-09-19 | Semi-Annually | 0 | 0.00% | |
1818.HK | Ex Dividend Junior | 2023-06-07 | Annually | 0 | 0.00% | |
0848.HK | Ex Dividend Junior | 2023-05-24 | Annually | 0 | 0.00% | |
0006.HK | Ex Dividend Knight | 2023-08-30 | Semi-Annually | 0 | 0.00% | |
2588.HK | Ex Dividend Knight | 2023-09-25 | Semi-Annually | 0 | 0.00% | |
1382.HK | Ex Dividend Knight | 2023-08-15 | Semi-Annually | 0 | 0.00% | |
0455.HK | Ex Dividend Junior | 2023-06-29 | Annually | 0 | 0.00% | |
6823.HK | Ex Dividend Knight | 2023-08-17 | Semi-Annually | 0 | 0.00% | |
1931.HK | Ex Dividend Knight | 2023-09-04 | Semi-Annually | 0 | 0.00% | |
0966.HK | Ex Dividend Junior | 2023-07-10 | Sporadic | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0576 | 1.500 | 8.85 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0210 | 1.200 | 9.30 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0523 | 1.500 | -0.530 | -0.795 | [0.1 - 1] |
payoutRatioTTM | 1.029 | -1.000 | 10.00 | -10.00 | [0 - 1] |
currentRatioTTM | 1.001 | 0.800 | 9.99 | 8.00 | [1 - 3] |
quickRatioTTM | 0.757 | 0.800 | -0.254 | -0.203 | [0.8 - 2.5] |
cashRatioTTM | 0.406 | 1.500 | 8.86 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.309 | -1.500 | 4.84 | -7.26 | [0 - 0.6] |
interestCoverageTTM | 2.50 | 1.000 | -0.186 | -0.186 | [3 - 30] |
operatingCashFlowPerShareTTM | 1.173 | 2.00 | 9.61 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | -0.601 | 2.00 | -0.301 | -0.601 | [0 - 20] |
debtEquityRatioTTM | 0.769 | -1.500 | 6.93 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.478 | 1.000 | 5.36 | 5.36 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0799 | 1.000 | -0.402 | -0.402 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.100 | 1.000 | -0.553 | -0.553 | [0.2 - 2] |
assetTurnoverTTM | 0.365 | 0.800 | -0.901 | -0.721 | [0.5 - 2] |
Total Score | 7.35 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 14.55 | 1.000 | 8.63 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0523 | 2.50 | -0.341 | -0.795 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -0.601 | 2.00 | -0.200 | -0.601 | [0 - 30] |
dividendYielPercentageTTM | 3.98 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 1.173 | 2.00 | 9.61 | 10.00 | [0 - 30] |
payoutRatioTTM | 1.029 | 1.500 | 10.00 | -10.00 | [0 - 1] |
pegRatioTTM | 6.62 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0852 | 1.000 | -0.370 | 0 | [0.1 - 0.5] |
Total Score | 4.70 |
Shanghai Fosun
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. develops, manufactures, and sells pharmaceutical products in Mainland China and internationally. It operates in five segments: Pharmaceutical Manufacturing, Medical Devices and Medical Diagnosis, Healthcare Service, Pharmaceutical Distribution and Retail, Other Business segments. The company offers pharmaceutical products in the areas of tumor, immune modulation, metabolism, alimentary and central nervous system. It also provides medical devices and diagnostic products. In addition, the company offers health care and hospital management services. Further, it engages in retail and wholesale distribution of medicines. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.
के बारे में लाइव सिग्नल्स
इस पृष्ठ पर प्रस्तुत लाइव सिग्नल्स NA को कब खरीदना या बेचना है, इसका निर्धारण करने में मदद करते हैं। सिग्नल्स में 1-मिनट की देरी हो सकती है; सभी बाजार सिग्नल्स की तरह, त्रुटि या गलतियों की संभावना होती है।
लाइव ट्रेडिंग सिग्नल्स स्थायी नहीं हैं, और getagraph.com इन सिग्नल्स पर किए गए किसी भी कार्रवाई के लिए जिम्मेदारी नहीं रखते हैं, जैसा कि उपयोग की शर्तें में वर्णित है। सिग्नल्स एक व्यापक श्रृंखला के तकनीकी विश्लेषण संकेतकों पर आधारित हैं